Replies to post #208552 on Biotech Values

[DewDiligence]

RIGL sold 2.3M* shares @$2.00 yesterday—a 4% discount to Monday’s closing price:

http://finance.yahoo.com/news/rigel-announces-pricing-public-offering-123000995.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

RIGL +33%(!) on lack of FDA advisory panel for Fostamatinib in ITP:

http://www.prnewswire.com/news-releases/rigel-provides-update-on-fda-review-of-fostamatinib-for-itp-300528892.html